L’équipe du Dr Sauvageau, à l’Institut de Recherches Cliniques de Montréal, a identifié des molécules permettant de différencier les cellules cancéreuses du sein des cellules normales. Ils espèrent que cette découverte permettra le développement de nouvelles thérapies plus efficaces et avec moins d’effets secondaires. Précédemment caractérisés comme la « poubelle » des cellules du corps, les lncARNs pourraient être la source de nombreux nouveaux traitements.

- Sophie Ehresmann, PhD candidate

Omega-3 fatty acids, a unique type of fat found mostly in fish, have been shown to have anti-inflammatory properties. People living with Type 2 Diabetes (T2D) have dysfunctional fat tissue that is accompanied by chronic inflammation. Not only does the Faraj team aim to treat common risk factors for T2D using omega-3 fatty acids, but they also want to uncover the underlying mechanisms which have remained elusive for so long.

- Benjamin Ouimet, PhD candidate

Cancer progression frequently occurs due to genetic modifications in RAS proteins. To fight against RAS-driven cancers, Jean-François Côté and his research team at the Montreal Clinical Research Institute, along with other Canadian researchers, is working to build fundamental knowledge necessary for the development of new therapeutic strategies.

- Laura Quirion, PhD candidate